SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
Sernova Biotherapeutics Announces Warrant Amendments
February 20, 2026
 · 
3 min read
Press Releases
Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
This Press Release identifies that Dr. Kulkarni has participated in a medical advisory position for Theralase(R) in the past.
February 20, 2026
 · 
8 min read
Press Releases
From AI-driven drug discovery to the era of “cell debugging.” - Commentary by Unexakorea
February 20, 2026
 · 
1 min read
Press Releases
Organic Longevity Biotechnology: A New Paradigm for Anti-Aging, Lifespan Extension, and Rejuvenation
February 20, 2026
 · 
1 min read
Press Releases
MDCE CEO Expands Open-Market Position to 66,199,283 Shares After Previously Returning Nearly 2 Billion Shares to Treasury
February 20, 2026
 · 
3 min read
Press Releases
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
February 20, 2026
 · 
1 min read
Press Releases
Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026
February 20, 2026
 · 
1 min read
Press Releases
ImmunityBio Partners with Biopharma and Cigalah Healthcare to Launch ANKTIVA® in Saudi Arabia for Bladder and Lung Cancer Patients
February 20, 2026
 · 
10 min read
Press Releases
enGene to Participate in Upcoming Investor Conferences - February 20, 2026
February 20, 2026
 · 
1 min read
Press Releases
Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference
February 20, 2026
 · 
1 min read
Press Releases
CORRECTION FROM SOURCE: The Nomination Committee’s Proposal for New Board Members
February 20, 2026
 · 
2 min read
Press Releases
PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval
February 20, 2026
 · 
6 min read
Press Releases
Zelluna Receives UK MHRA and Ethics Approval to Initiate ZIMA-101 First-in-Human Clinical Trial
February 20, 2026
 · 
4 min read
Press Releases
CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference
February 20, 2026
 · 
4 min read
Press Releases
Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development
February 20, 2026
 · 
4 min read
Press Releases
Annual General Meeting in ALK-Abelló A/S on 16 March 2026
February 20, 2026
 · 
1 min read
Press Releases
Zenocutuzumab Treatment Beyond Progression Demonstrates Continued Benefit in Patients with NRG1+ Non-Small Cell Lung Cancer: New Results from the eNRGy Trial
February 20, 2026
 · 
10 min read
Press Releases
The Nomination Committee of XVIVO Perfusion AB (publ) Proposes Emil Billbäck and Anne-Karen Hunt as New Members of the Board of Directors
February 20, 2026
 · 
2 min read
Press Releases
ABLi Therapeutics Announces Publication of the Final Results from the Phase 2 ‘201 Trial’ Evaluating Risvodetinib for the Treatment of Parkinson’s Disease
February 20, 2026
 · 
3 min read
Press Releases
Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference
February 20, 2026
 · 
5 min read
Press Releases
AltruBio Announces Formation of Inflammatory Bowel Disease Clinical Advisory Board
February 20, 2026
 · 
7 min read
Press Releases
Nasus Pharma to Participate in Upcoming Investor Conferences - February 20, 2026
February 20, 2026
 · 
1 min read
Press Releases
Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements
February 20, 2026
 · 
5 min read
Press Releases
Telix to Participate in Oppenheimer and TD Cowen Conferences
February 20, 2026
 · 
5 min read
Press Releases
Asahi Kasei Pharma and Alchemedicine Advance a Novel Therapeutic Candidate Into Phase I Study for the Treatment of Refractory Diseases
February 18, 2026
 · 
3 min read
Press Releases
Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology
February 18, 2026
 · 
6 min read
Press Releases
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - February 18, 2026
February 18, 2026
 · 
2 min read
Press Releases
Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens
February 18, 2026
 · 
4 min read
Press Releases
FDA Approval Granted for Commercial Manufacturing at Rezon Bio’s Warsaw-Duchnice Facility
February 18, 2026
 · 
3 min read
Press Releases
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement
February 18, 2026
 · 
11 min read
Press Releases
GSK’s AREXVY Associated With Reductions in Certain RSV-Related Risks Including Heart Attack, Stroke and Severe Flare-Ups of COPD and Asthma, Real World Study Shows
February 18, 2026
 · 
15 min read
Press Releases
Scholar Rock to Present at Upcoming March 2026 Investor Conferences
February 18, 2026
 · 
2 min read
Press Releases
Catalent and S.Biomedics Announce Partnership to Develop and Manufacture TED‑A9
February 18, 2026
 · 
3 min read
Press Releases
Maestro MEA Platform Powers First Stem Cell Cardiac Safety Assay in FDA ISTAND Program
February 18, 2026
 · 
3 min read
Load More